Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY (PTC-ARRAY)

Istituto Auxologico Italiano

Status: Enrolling

Conditions: Papillary Thyroid Cancer

Treatments: Genetic: Genotyping

Study type: Observational

Funder types: Other

Identifiers

NCT05766098

05C825

Details and patient eligibility

About

Somatic mutations in the MAP (mitogen-activated protein) kinase pathway have been found in about 80% of papillary thyroid tumors (PTCs). The evaluation of the PTC mutational profile is crucial for the definition of the prognosis and for predicting the effects of targeted and personalized therapies. Molecular characterization by mass spectrometry (Mass ARRAY) allows the search for multiple mutations in a single experiment, in a sensitive, fast and economic way. A Mass ARRAY platform (PTC-MA) was developed, capable of identifying the presence of the most common somatic point mutations and rearrangements in PTC (Pesenti et al., Endocrine 2017). The aim of the study is to characterize the mutational profile of a large series of papillary thyroid carcinomas (PTC). Tumor samples will be analyzed using our PTC-MA platform. The molecular profile of PTCs will be correlated with the clinical and prognostic characteristics of the patients.

Enrollment: 600 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with papillary thyroid cancer
• patients whose tumor tissue can be recovered for genetic analysis

Exclusion criteria

• patients who did not give consent
• patients lost to follow-up
• tumor samples not suitable for genetic analysis

Trial design

600 participants in 1 patient group

Patients with papillary thyroid cancer

Treatment:

Genetic: Genotyping